Therefore, we concluded that downregulated NEDD4L in ccRCC might lead to metabolic disorder and immune deficiency, inhibit cell apoptosis, promote cell growth, migration, and adhesion, and further induce the development of ccRCC. Here, NEDD4L is linked to metabolic disease.